Detalles de la búsqueda
1.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882736
2.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Breast Cancer Res Treat
; 173(2): 397-406, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357526
3.
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
Front Oncol
; 11: 781121, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087753
4.
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program.
Breast
; 56: 18-25, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33561617
5.
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
BMJ Open
; 9(2): e023568, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796119
6.
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
Eur J Cancer
; 118: 131-141, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330488
7.
[Outpatient chemotherapy and oncology network : Onco Pays-de-la-Loire experiment]. / Chimiothérapie à domicile et réseau ville-hôpital : expérience du réseau Onco Pays-de-la-Loire.
Bull Cancer
; 95(5): 543-9, 2008 May.
Artículo
en Francés
| MEDLINE | ID: mdl-18541519
Resultados
1 -
7
de 7
1
Próxima >
>>